Detalhe da pesquisa
1.
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 403(10429): 813-823, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387470
2.
Sex differences in the incidence and clearance of anal human papillomavirus infection among heterosexual men and women in Liuzhou, China: An observational cohort study.
Int J Cancer
; 145(3): 807-816, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30848495
3.
Effects of cytotoxin-associated gene A (CagA) positive Helicobacter pylori infection on anti-platelet glycoprotein antibody producing B cells in patients with primary idiopathic thrombocytopenic purpura (ITP).
Pak J Med Sci
; 31(1): 121-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25878627
4.
Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial.
Emerg Microbes Infect
; 12(1): 2185456, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877135
5.
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters.
Nat Commun
; 14(1): 4117, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433761
6.
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Respir Med
; 11(12): 1075-1088, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979588
7.
Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective.
Front Microbiol
; 13: 828806, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35273584
8.
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
Emerg Microbes Infect
; 11(1): 793-803, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35195494
9.
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.
Sci Bull (Beijing)
; 67(13): 1372-1387, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637645
10.
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Lancet Respir Med
; 10(8): 749-760, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644168
11.
Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population.
Emerg Microbes Infect
; 10(1): 1824-1831, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392819
12.
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.
Emerg Microbes Infect
; 10(1): 365-375, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33583360